Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death).
about
The role of inflammation in cardiovascular diseases: the predictive value of neutrophil-lymphocyte ratio as a marker in peripheral arterial diseaseExercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefitsBiomarkers and Genetics in Peripheral Artery Disease.Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study.n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial.Relationship between the plasma concentration of C-reactive protein and severity of peripheral arterial diseaseNovel markers of peripheral arterial disease.The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart diseaseGender-specific risk factors for peripheral artery disease in a voluntary screening population.Peripheral arterial disease, gender, and depression in the Heart and Soul StudyAssociation between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease.Clinical correlates of red blood cell omega-3 fatty acid content in male veterans with peripheral arterial disease.Relationship between kidney disease and endothelial function in peripheral artery diseaseAssociation of monocyte tumor necrosis factor α expression and serum inflammatory biomarkers with walking impairment in peripheral artery disease.Decrease in circulating dendritic cell precursors in patients with peripheral artery diseasePrognostic significance of ankle brachial pressure index: A systematic review and meta-analysis.Physical activity during daily life and circulating biomarker levels in patients with peripheral arterial disease.Sex-based differences in the inflammatory profile of peripheral artery disease and the association with primary patency of lower extremity vein bypass grafts.Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial)Carotid arterial wall inflammation in peripheral artery disease is augmented by type 2 diabetes: a cross-sectional studyPrevalent peripheral arterial disease and inflammatory burden.Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgeryDiagnosis and management of peripheral artery disease in women.Early remodeling of lower extremity vein grafts: inflammation influences biomechanical adaptation.Risk assessment in the patient with established peripheral arterial disease.Increased risk of peripheral arterial disease in polymyalgia rheumatica: a population-based cohort study.Cross-sectional relations of multiple inflammatory biomarkers to peripheral arterial disease: The Framingham Offspring Study.Association of insulin resistance and inflammation with peripheral arterial disease: the National Health and Nutrition Examination Survey, 1999 to 2004Percutaneous Transluminal Angioplasty in Patients with Peripheral Arterial Disease Does Not Affect Circulating Monocyte Subpopulations.White blood cell count predicts all-cause mortality in patients with suspected peripheral arterial diseaseHigh-Density Lipoprotein Subfractions and Cholesterol Efflux Capacity Are Not Affected by Supervised Exercise but Are Associated with Baseline Interleukin-6 in Patients with Peripheral Artery DiseaseSerum biomarkers as signals for risk and severity of work-related musculoskeletal injury.C-reactive protein predicts future arterial and cardiovascular events in patients with symptomatic peripheral arterial disease.Red cell distribution width and risk of peripheral artery disease: analysis of National Health and Nutrition Examination Survey 1999-2004.Short-term effects of an anti-inflammatory treatment on clinical parameters and serum levels of C-reactive protein and proinflammatory cytokines in subjects with periodontitis.Relationship between high-sensitivity C-reactive protein and risk factors in patients with peripheral arterial disease--a cross-sectional study.Endothelial progenitor cells as a biological marker of peripheral artery disease.
P2860
Q26745592-026C544B-0B85-42B9-9466-C8EB98511A27Q27694706-5C23F3C7-E3EA-4820-90E2-573364CD952EQ30240841-A42438EB-D85F-4DE9-ABA2-809FFF22A40BQ30595680-6BFF06C3-C1FA-40E9-8984-B1D494823654Q33819705-B52AEE57-BBF2-423F-8A58-EEFFD96E7FF9Q33860219-E8A7ADCB-10B8-4E3D-889D-8817E8930EADQ33984026-80B24C89-419D-4C6D-A297-AA40AFBFF8C0Q34033670-B1B7E67C-6B03-4FB5-93FB-BB3F297AE064Q34297119-D4F8D76B-8B98-458D-9E6C-D1B1687032BEQ34349272-E47E8616-04F8-40D9-BB11-BC858A4A77F5Q34391653-A9468076-3A78-44D8-AC88-9F35F4115E3BQ34621812-92D55776-26E0-4259-9463-ED72D3AEA908Q34624905-5E3DBB28-739C-4CEC-A8EB-310BDBE4A006Q34772426-4372641C-98FA-404E-966E-68A3DA23A57CQ35551273-61D2022F-A194-4A5D-837F-69B2A5BBDBD8Q36076455-0DBBAF83-6996-4588-8F4F-BAF34B9ADAE8Q36114516-1CBA786E-6E9E-459F-998E-8481E8A83691Q36129316-F2437B9C-CE17-4B57-9E2F-276E7285B309Q36141602-BD27B7A8-D0BF-4017-9181-42D5CB2E05E1Q36204111-06EA4E31-01C3-4563-A4AE-12CF2DC43F8FQ36219072-0A89B86E-D94C-4387-8BFD-26A52A70ED88Q36369429-0DBB39D8-BC72-40CF-807C-BDC5FD5BB220Q36493454-67BE88BE-B614-4BD8-9526-874B58517680Q36951957-D60841BB-BABC-4634-9AE0-A1052A765D68Q37019601-62B3A4F1-F811-42A0-9725-194573E5C47DQ37206968-D25AC8CA-F22F-49EF-A618-CAF2F40351D1Q37212527-77778F12-7105-42DD-955B-CC4F513F2548Q37246522-C513ACE9-7A63-4ECE-8121-94C9FF86D728Q37368874-C6260C14-18E4-4D96-A1A3-7940CC1DA993Q37445745-3E85C768-0441-42E9-A863-059F4E453D97Q37675416-CD9C1FB4-CC22-41A1-8A24-313E613A527BQ37755049-E97B16B7-3396-447A-AA9F-BE0C82740185Q40095311-4818F89E-0A17-40AB-824E-48D38063B0E8Q43615743-07C0F677-C24E-462A-B502-DC9440F68747Q45988045-FD81632A-366E-4A7F-AB50-830406D08D4CQ48698039-49C08988-BCFF-4017-94DA-8BA7B18E86E5Q50765552-3A1CCCC2-2AB6-4083-B79C-2348C011E223
P2860
Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death).
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Comparison of usefulness of in ...... nfarction, stroke, and death).
@en
Comparison of usefulness of in ...... nfarction, stroke, and death).
@nl
type
label
Comparison of usefulness of in ...... nfarction, stroke, and death).
@en
Comparison of usefulness of in ...... nfarction, stroke, and death).
@nl
prefLabel
Comparison of usefulness of in ...... nfarction, stroke, and death).
@en
Comparison of usefulness of in ...... nfarction, stroke, and death).
@nl
P2093
P1476
Comparison of usefulness of in ...... nfarction, stroke, and death).
@en
P2093
Marie Gerhard-Herman
Paul M Ridker
P304
P356
10.1016/J.AMJCARD.2005.07.041
P407
P577
2005-09-27T00:00:00Z